ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,255,000 | +372.3% | 1,037,736 | +311.3% | 0.01% | +300.0% |
| Q4 2021 | $901,000 | -78.6% | 252,293 | -78.2% | 0.00% | -76.9% |
| Q3 2021 | $4,220,000 | -21.4% | 1,159,446 | -5.8% | 0.01% | -27.8% |
| Q2 2021 | $5,367,000 | +99.4% | 1,230,961 | +87.9% | 0.02% | +63.6% |
| Q1 2021 | $2,692,000 | +112.0% | 655,051 | +105.8% | 0.01% | +83.3% |
| Q4 2020 | $1,270,000 | -10.3% | 318,263 | -39.3% | 0.01% | -25.0% |
| Q3 2020 | $1,416,000 | +13.5% | 524,565 | +15.6% | 0.01% | 0.0% |
| Q2 2020 | $1,248,000 | +2169.1% | 453,770 | +1838.4% | 0.01% | – |
| Q1 2020 | $55,000 | – | 23,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |